Filing Details

Accession Number:
0001437749-17-015179
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-22 18:19:27
Reporting Period:
2017-08-22
Accepted Time:
2017-08-22 17:19:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1427925 Acelrx Pharmaceuticals Inc ACRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1511365 P Pamela Palmer C/O Acelrx Pharmaceuticals, Inc.
351 Galveston Drive
Redwood City CA 94063
Chief Medical Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-22 10,000 $2.95 415,801 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This is a weighted average purchase price. Shares were purchased in the range of $2.9250 and $2.95.
  2. Balance includes non-reportable acquisition of 6,786 shares of Common Stock through the Company's Employee Stock Purchase Plan.